High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma

International Journal of Molecular Medicine

Volumn 32, Issue 5, 2013, Pages 1093-1100

  Yu, Tao ^a,b   Liu, Kun ^a   Wu, Yingying ^b   Fan, Jinchuan ^a   Chen, Jianchao ^a   Li, Chao ^a   Zhu, Guiquan ^a   Wang, Zhaohui ^a   Li, Longjiang ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Interstitial fluid pressure; Microarray; Oral squamous cell carcinoma; Tumor progression

Indexed keywords

STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CANCER PROGNOSIS; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; TISSUE PRESSURE; TONGUE CARCINOMA; TUMOR INVASION; VASCULARIZATION;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR FLUID; HUMANS; PRESSURE;

EID: 84885057064     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1496     Document Type: Article

References (29)

1. Cairns R, Papandreou I and Denko N: Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 4: 61-70, 2006.
2. Lunt SJ, Fyles A, Hill RP and Milosevic M: Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angio-genesis. Future Oncol 4 793-802, 2008.
3. Gutmann R, Leunig M, Feyh J., et al.: Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res 52: 1993-1995, 1992.
4. Fukumura D and Jain RK: Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101: 937-949, 2007
5. Roh HD, Boucher Y, Kalnicki S., Buchsbaum R, Bloomer WD and Jain RK: Interstitial hypertension in carcinoma of uterine cervix in patients: possible correlation with tumor oxygenation and radiation response. Cancer Res 51: 6695-6698, 1991.
6. Milosevic M, Fyles A, Hedley D., et al.: Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 61: 6400-6405, 2001.
7. Rofstad EK, Tunheim SH, Mathiesen B, Graff B.A., Halsør EF, Nilsen K and Galappathi K: Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res 62: 661-664, 2002.
8. Fyles A, Milosevic M, Pintilie M., Syed A, Levin W, Manchul L and Hill RP: Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 80: 132-137, 2006.
9. Lunt SJ, Kalliomaki TM, Brown A, Yang V.X., Milosevic M and Hill RP: Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 8: 2, 2008.
10. de Aguiar A Jr, Kowalski LP and de Almeida OP: Clinico-pathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncology 43: 593-601, 2007
11. Parker B and Sukumar S: Distant metastasis in breast cancer: molecular mechanisms and therapeutic targets. Cancer Biol Ther 2: 14-21, 2003.
12. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
13. Young JS, Lumsden CE and Stalker AL The significance of the tissue pressure of normal testicular and of neoplastic (Brown-Pearce carcinoma) tissue in the rabbit. J Pathol Bacteriol 62: 313-333, 1950.
14. Basson MD, Yu CF and Herden-Kirchoff O: Effects of increased ambient pressure on colon cancer cell adhesion. J Cell Biochem 78: 47-61, 2000.
15. Thamilselvan V and Basson MD: Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling. Gastroenterology 126: 8-18, 2004.
16. van der Voort van Zyp J, Thamilselvan V, Walsh M, Polin L and Basson MD: Extracellular pressure stimulates colon cancer cell adhesion in vitro and to surgical wounds by Src (sarcoma protein) activation. Am J Surg 188: 467-473, 2004.
17. Lazaris AC, Theodoropoulos GE, Davaris P.S., Panoussopoulos P., Nakopoulos L, Kittas C and Golematis BC: Heat shock protein 70 and HLA-DR molecules tissue expression. Prognostic implication in colorectal cancer. Dis Colon Rectum 38: 739-745, 1995.
18. Lazaris AC, Chatzigianni EB, Panoussopoulos D, Tzimas G.N., Davaris PS and Golematis BC: Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified. Breast Cancer Res Treat 43: 43-51, 1997.
19. Bauer K, Nitsche U, Slotta-Huspenina J, et al.: High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer. Cell Oncol (Dordr) 35: 197-205, 2012.
20. Quintayo MA, Munro AF, Thomas J, et al.: GSK3β and cyclin D1 expression predicts outcome in early breast cancer patients. Breast Cancer Res Treat 136: 161-168, 2012.
21. Shih LC, Tsai CW, Tsai M.H., et al.: Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Anticancer Res 32: 1093-1098, 2012.
22. Huang SF, Cheng SD, Chuang W.Y., et al.: Cyclin D1 overex-pression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma. World J Surg Oncol 10: 40, 2012.
23. Polyak K, Kato JY, Solomon M.J., et al.: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8: 9-22, 1994.
24. Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
25. Moeller BJ, Richardson RA and Dewhirst MW: Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26: 241-248, 2007.
26. Cerniglia GJ, Pore N, Tsai J.H., et al.: Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy. PLoS One 4: 8, 2009.
27. Liao D and Johnson RS: Hypoxia: a key regulator of angiogen-esis in cancer. Cancer Metastasis Rev 26: 281-290, 2007.
28. Carmeliet P: Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
29. Mizobuchi H, García-Castellano JM, Philip S, et al.: Hypoxia markers in human osteosarcoma: an exploratory study. Clin Orthop Relat Res 466: 2052-2059, 2008.